ArticleJournal of the Endocrine Society2025
Geographical Variation in Adrenocortical Carcinoma Incidence Across Colorado.
Article in Journal of the Endocrine Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perspectives on Adrenal Tumor Surgery.Medicina (Kaunas, Lithuania) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Adrenocortical carcinoma (ACC) is an aggressive endocrine malignancy with an annual incidence of approximately 1 case per million, with the underlying etiology poorly understood. We retrospectively investigated the geographic distribution of 62 ACC cases diagnosed between 2010 and 2023 and of 115 pheochromocytoma/paraganglioma (PPGL) diagnosed between 2016 and 2023 at the University of Colorado Hospital, as well as 115 ACC cases diagnosed between 2012 and 2020 from the Colorado Central Cancer Registry (CCCR). Data on patient age, sex, zip code of residence, and tumor characteristics were collected and, for ACC cases, compared with CCCR data. Our University of Colorado cohort showed an average ACC annual incidence of 0.81 cases per million, with 61.2% of cases occurring in women. The CCCR cohort showed an average ACC annual incidence of 1.1 cases per million, with 48.7% of cases in women. For PPGL, the average annual incidence was 2.26 cases per million, with 60% of cases occurring in females. Our ACC cohort had an average annual incidence of 1.36 cases per million in Western Colorado and 0.68 cases per million in Eastern Colorado. Similarly, the state registry showed 1.49 cases per million in Western Colorado and 1 case per million in Eastern Colorado. In contrast, PPGL data showed 1.35 cases per million in Western Colorado and 2.36 cases per million in Eastern Colorado. These data suggest a higher incidence of ACC in Western Colorado, highlighting the need for investigation into environmental factors as potential pathogenic factors in ACC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.